Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular thiols, primarily represented by the tripeptide glutathione (GSH), serve as the fundamental redox buffer within the intracellular environment, maintaining the balance between reduced and oxidized states. These molecules are characterized by reactive sulfhydryl (-SH) groups that participate in thiol-disulfide exchange reactions, which are essential for protein folding, enzyme regulation, and protection against oxidative stress (Meister, A., 1988, J. Biol. Chem.; Forman, H. J., et al., 2009, Mol. Aspects Med.). In a pharmacological context, cellular thiols act as the functional target for disulfide-based drugs like cystamine. Upon cellular entry, cystamine undergoes a non-enzymatic thiol-disulfide exchange with endogenous GSH, resulting in the release of cysteamine (PubChem CID 311). This mechanism is the basis for treating cystinosis, a lysosomal storage disorder; the released cysteamine reacts with accumulated lysosomal cystine to form a mixed disulfide that can exit the lysosome via the PQLC2 transporter (Gahl, W. A., et al., 2002, N. Engl. J. Med.). Additionally, the interaction with cellular thiols is investigated for neuroprotective effects in diseases like Huntington's, where cystamine may inhibit transglutaminase or modulate antioxidant responses (Karpuj, M. V., et al., 2002, Nat. Med.). Monitoring the balance of these thiol pools is crucial, as excessive depletion can lead to oxidative stress and cellular damage.
Thiol-disulfide exchange leading to the release of active thiol moieties (e.g., cysteamine)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular thiols (GSH).